Panagora Asset Management Inc Affimed N.V. Transaction History

Panagora Asset Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.66 - $1.29 $43,312 - $84,656	-65,625 Reduced 17.21%	315,755 $236,000
Q4 2022 Feb 13, 2023	BUY	$1.1 - $2.45 $167,176 - $372,348	151,979 Added 66.25%	381,380 $472,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.32 $401,486 - $680,068	204,840 Added 834.01%	229,401 $473,000
Q2 2022 Aug 15, 2022	BUY	$2.27 - $4.86 $55,753 - $119,366	24,561 New	24,561 $68,000
Q1 2022 May 12, 2022	SELL	$3.69 - $5.65 $1.33 Million - $2.04 Million	-361,183 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$5.37 - $7.07 $378,703 - $498,590	-70,522 Reduced 16.34%	361,183 $1.99 Million
Q3 2021 Nov 10, 2021	SELL	$5.54 - $7.51 $69,155 - $93,747	-12,483 Reduced 2.81%	431,705 $2.67 Million
Q2 2021 Aug 11, 2021	BUY	$7.78 - $11.4 $1.1 Million - $1.61 Million	141,323 Added 46.66%	444,188 $3.78 Million
Q1 2021 May 12, 2021	SELL	$5.12 - $8.48 $1.52 Million - $2.52 Million	-296,650 Reduced 49.48%	302,865 $2.4 Million
Q4 2020 Feb 10, 2021	SELL	$3.16 - $7.03 $24,271 - $53,997	-7,681 Reduced 1.26%	599,515 $3.49 Million
Q3 2020 Nov 13, 2020	SELL	$3.26 - $4.73 $283,721 - $411,656	-87,031 Reduced 12.54%	607,196 $2.06 Million
Q2 2020 Aug 12, 2020	BUY	$1.58 - $4.63 $451,979 - $1.32 Million	286,063 Added 70.09%	694,227 $3.2 Million
Q1 2020 May 14, 2020	BUY	$1.44 - $3.02 $587,756 - $1.23 Million	408,164 New	408,164 $645,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.